Multiple Ascending Dose Study of BMS-754807 in Patients With Solid Tumors in Japan
NCT00898716
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
15
Enrollment
INDUSTRY
Sponsor class
Conditions
Neoplasms
Interventions
DRUG:
BMS-754807
Sponsor
Bristol-Myers Squibb